Effah Kofi, Tekpor Ethel, Amuah Joseph Emmanuel, Essel Nana Owusu M, Kemawor Seyram, Catherine Morkli Esu Aku, Lamptey-Mills Esther, Wormenor Comfort Mawusi, Manu Lawrencia Serwaa, Klutsey Gifty Belinda, Danyo Stephen, Akakpo Patrick Kafui
Cervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Department of Obstetrics and Gynecology, Catholic Hospital, Battor, Ghana.
EClinicalMedicine. 2023 Aug 31;63:102183. doi: 10.1016/j.eclinm.2023.102183. eCollection 2023 Sep.
The need for cervical cancer screening has been emphasised in at-risk cohorts of women to reduce their risk of cervical cancer. Some women with decreased risk of acquiring human papillomavirus (HPV) infections, such as Catholic nuns, receive less attention and on occasion are missed in cervical cancer screening programmes. This study aimed to determine the high-risk HPV (hr-HPV) prevalence in such a cohort to emphasise the need for cervical precancer screening among all women. To improve compliance, we employed self-sampling.
This descriptive cross-sectional cohort study involved the data of 105 Catholic nuns subjected to cervical screening using self-samples in the Greater Accra, Volta, and Central regions of Ghana between June 4, 2022 and June 30, 2022. hr-HPV testing was performed on self-samples using the MA-6000 HPV DNA platform. Screen-positive nuns underwent follow-up pap smears and EVA colposcopy. In addition to descriptive analysis, univariate and multivariable nominal logistic regression was used to explore the relationship between hr-HPV positivity and selected continuous and categorical factors.
105 nuns from three convents were screened with hr-HPV DNA testing (MA-6000). Twenty-five tested positive for hr-HPV (prevalence of 23.8% (95% CI, 15.7-32.0) [HPV 18 only (n = 2, 1.9%), non-HPV 16/18 genotypes () (n = 22, 21.0%), and mixed infection with HPV 16 and genotype(s) (n = 1, 1.0%)]. Pap smears for all 25 hr-HPV-positives came in as negative for intraepithelial lesions or malignancy, whereas EVA mobile colposcopy showed minor abnormal findings in two (8.0%; 95% CI, 1.0-26.0), both of whom were managed conservatively.
Our findings suggest that the hr-HPV prevalence in this cohort of nuns is similar to that of the general population. To meet the World Health Organization's target for cervical cancer elimination, it is important that all women are given access to cervical cancer screening and preventative services. Further, increasing 'anonymity' and privacy among nuns through self-sampling may be crucial to expanding choice, coverage, and uptake of screening in support of their health rights.
None.
为降低宫颈癌风险,高危女性群体的宫颈癌筛查需求已得到强调。一些感染人乳头瘤病毒(HPV)风险较低的女性,如天主教修女,受到的关注较少,在宫颈癌筛查项目中有时会被遗漏。本研究旨在确定此类人群中的高危型HPV(hr-HPV)流行率,以强调所有女性进行宫颈癌前筛查的必要性。为提高依从性,我们采用了自我采样。
这项描述性横断面队列研究纳入了2022年6月4日至2022年6月30日期间在加纳大阿克拉、沃尔特和中部地区对105名天主教修女进行自我采样宫颈筛查的数据。使用MA-6000 HPV DNA平台对自我采样样本进行hr-HPV检测。筛查阳性的修女接受了后续的巴氏涂片检查和EVA阴道镜检查。除描述性分析外,还使用单变量和多变量名义逻辑回归来探讨hr-HPV阳性与选定的连续和分类因素之间的关系。
对来自三个女修道院的105名修女进行了hr-HPV DNA检测(MA-6000)。25人hr-HPV检测呈阳性(流行率为23.8%(95%CI,15.7 - 32.0)[仅HPV 18阳性(n = 2,1.9%),非HPV 16/18基因型()(n = 22,21.0%),以及HPV 16与其他基因型混合感染(n = 1,1.0%)]。所有25名hr-HPV阳性者的巴氏涂片检查结果均为上皮内病变或恶性肿瘤阴性,而EVA移动阴道镜检查在两名修女中发现轻微异常(8.0%;95%CI,1.0 - 26.0),两人均接受了保守治疗。
我们的研究结果表明,该修女群体中的hr-HPV流行率与普通人群相似。为实现世界卫生组织消除宫颈癌的目标,让所有女性都能获得宫颈癌筛查和预防服务非常重要。此外,通过自我采样增加修女的“匿名性”和隐私性,对于扩大筛查的选择、覆盖范围和接受度以支持她们的健康权利可能至关重要。
无。